Chordia Therapeutics (TSE:190A) Common Stock: 円1,128.56 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:190A Chordia Therapeutics Inc TSE:190A
12 GF Score
Price 円78.00
! 2 Warning Signs
View Full Analysis

What is Chordia Therapeutics Common Stock?

Chordia Therapeutics TSE:190A 12 Common Stock is 円1,128.56 Mil as of Feb. 2026. GuruFocus rates TSE:190A with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Chordia Therapeutics's quarterly common stock stayed the same from Feb. 2025 (円876.27 Mil) to Aug. 2025 (円876.27 Mil) but then increased from Aug. 2025 (円876.27 Mil) to Feb. 2026 (円1,128.56 Mil).

Chordia Therapeutics's annual common stock increased from Aug. 2023 (円90.00 Mil) to Aug. 2024 (円845.27 Mil) and increased from Aug. 2024 (円845.27 Mil) to Aug. 2025 (円876.27 Mil).

Chordia Therapeutics Common Stock Historical Data

* Premium members only.

The historical data trend for Chordia Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordia Therapeutics Common Stock Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24 Aug25
Common Stock
92.50 90.00 90.00 845.27 876.27

Chordia Therapeutics Semi-Annual Data
Aug21 Aug22 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Common Stock Get a 7-Day Free Trial 0.00 845.27 876.27 876.27 1,128.56
TSE:190A
12GF Score
Chordia Therapeutics Inc TSE:190A
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chordia Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of 円1,128.56 Mil mean?
Chordia Therapeutics (TSE:190A) has a Common Stock of 円1,128.56 Mil as of Feb. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Chordia Therapeutics and its competitors.
Is Chordia Therapeutics' Common Stock too high?
Chordia Therapeutics' current Common Stock is 円1,128.56 Mil. Overall, Chordia Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Chordia Therapeutics' Common Stock compare to VRTX and REGN?
Chordia Therapeutics' Common Stock of 円1,128.56 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Chordia Therapeutics and its competitors. Chordia Therapeutics's current Common Stock is 円1,128.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chordia Therapeutics stock overvalued right now?
Chordia Therapeutics (TSE:190A) has a current Common Stock of 円1,128.56 Mil. The current Common Stock is 円1,128.56 Mil. Chordia Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Chordia Therapeutics (TSE:190A), the current Common Stock is 円1,128.56 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chordia Therapeutics Business Description

Address 2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
12GF Score

Get the complete analysis for TSE:190A

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円78.00
Price